Total investments received (USD): 38.11M
Round value (USD): 10M
Company: Aurealis Pharma
Related deals
iDEL Therapeutics raised €9m in seed funding led by BioMedVC, joined by NRW.Venture, Gründerfonds Ruhr and KHAN Technology Transfer
Investments
02 March 2026
Syndex Bio in a $15.5M seed round led by ARCH Venture Partners
Investments
14 February 2026
4Moving Biotech raised a €12 million financing with 4P-Pharma, Fondation Arthritis, SATT Lutech, Business Angels, Family Offices in France
Investments
17 January 2026
Apmonia Therapeutics raised €10M series A with Capital Grand Est, Finovam Gestion, Fondation Fournier-Majoie, Angels Santé, Capital Cell in France
Investments
09 January 2026
ErVimmune raised €17 million Series A financing with Seventure and SPRIM Global
Investments
06 January 2026
Netherlands
Austria
Denmark
Estonia
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Italy
Portugal